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Haemorrhage is the primary complication of anticoagulation therapy with the gastrointestinal, urinary and nasal
tracts the most common sites of bleeding. Haematoma within solid organs is uncommon especially in the absence
of blunt trauma. We describe two patients on long term Warfarin therapy who developed focal haematomas within
the pancreas. To the best of our knowledge these are the first isolated unprovoked focal pancreatic hematoma
cases reported in the literature. The non-specific clinical symptoms and confusing radiological features mimicked
pancreatic malignancy and this led to misdiagnosis in the one patient who underwent unnecessary surgical
exploration. The haematoma was correctly identified in the second patient who was managed conservatively and
had an uneventful recovery.Background
Anticoagulation therapy is essential in preventing many
thromboembolic events and warfarin is the most com-
monly prescribed oral anticoagulation therapy. Unfortu-
nately, the pharmacokinetics and pharmacodynamics of
Warfarin are complex and its usage requires regular mon-
itoring. Haemorrhagic complications associated with war-
farin can cause significant morbidity and mortality to
patients [1].
We report two cases of isolated pancreatic haemorrhage
mimicking pancreatic malignancy and discuss the chal-
lenges in correctly diagnosing these two cases as well as
how to differentiate pancreatic malignancy and haemor-
rhage from its mimics.
Case presentation
The first patient was a 66 year-old male who presented
acutely to the surgical admissions unit in January 2011.
The patient had 4 episodes of fresh rectal bleeding
within 48 hours and non-specific abdominal pain. The
patient had had mechanical aortic valve replacement
four years previously for aortic stenosis. The patient had
also suffered from abdominal aortic aneurysm rupture
and had undergone an emergency open abdominal aorta
repair three years prior to this admission. The patient* Correspondence: keith.chiu@hey.nhs.uk
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reproduction in any medium, provided the orwas on multiple medications including amiodarone,
perindopril and long term Warfarin therapy.
On admission, the patient had a raised serum lactate
of 5.0 mmol/L, white cell count of 17.6 × 10^12/L
(neutophilia), a chronic normocytic anaemia of 9.4 g/dl
but no acute drop in haemoglobin level. The patient’s
anticoagulation was well controlled and had an inter-
national normalised Ratio (INR) of 3.1 that was within
therapeutic range for the patient. Other blood examin-
ation was normal. The surgical team was concerned that
there may be an aorto-enteric fistula in view of previous
aortic surgery. A Computed Tomography (CT) scan was
carried out and an unexpected 3 cm mass in the head of
pancreas was identified (Figure 1A). The patient under-
went an oesophagogastroduodenoscopy (OGD) and a
colonoscopy which were normal. The case was referred
to the hepato-pancreatico-biliary multidisciplinary meet-
ing (MDT) and the lesion was presumed to be a poten-
tially operable pancreatic adenocarcinoma. An MRI had
been suggested for further assessment of this lesion but
this was overlooked and decision was made for trial dis-
section with a view to perform a curative Whipple’s pro-
cedure. In July 2011, the patient underwent a laparotomy
and intra-operatively, the hepatobiliary surgeon was un-
able to identify the pancreatic lesion. An intra-operative
ultrasound was carried out by two experienced cross-
sectional radiologists that also failed to identify the lesion.
The laparotomy was abandoned.d. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 CT images of the first patient. (A) An 3 cm lesion was
seen on initial post contrast venous phase CT (white arrow). This was
mis-interpreted as a pancreatic malignancy. (B) Patient underwent a
laparotomy which failed to identify a mass in the pancreas. Post
operatively, he developed a wound site abscess (black arrow).
Figure 2 CT and MRI images of the second patient. (A) A large
heterogenous mass (white arrow) was identified at the head of
pancreas. This was identified as a haematoma. (B) Follow-up MRI
showed the pancreatic mass (black arrow) had decreased in size and
demonstrated characteristic signals for a haematoma.
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operative period and a follow-up CT scan 2 weeks post-
surgery showed that the pancreatic lesion had resolved
completely (Figure 1B). The patient went on to develop
an abscess in the wound site. He had debridement and
wash-out of the abscess under general anesthesia and
made an uneventful recovery thereafter.
The second patient was a 67 year-old female who was
admitted to the medical admissions unit in November
2011 with abdominal pain. The patient had mitral valve
repair nine months prior for mitral stenosis and had been
on Warfarin therapy since. The patient also suffered from
rheumatoid arthritis and was on methotrexate and pred-
nisolone. Initial blood examination showed a raised white
cell count of 17.6 × 10^12/L and a normocytic anaemia of
10.9 g/dl. Patient’s anticoagulation was poorly controlled
since beginning Warfarin therapy and on admission had
an INR of 9.5.
The patient’s anticoagulation therapy was stopped and
INR reversed back to normal while put on intravenousheparin. She also underwent an ultrasound scan that
demonstrated a large heterogeneous mass arising from
the pancreatic head. A CT scan was then carried out that
confirmed the presence of a pancreatic mass which was
thought to be a malignant lesion (Figure 2A).
The case was discussed in the hepato-pancreatico-
biliary MDT and on review the lesion was thought to be
a haematoma rather than a malignant lesion. A decision
to ‘watch and wait’ was adopted. The patient’s symp-
toms settled with conservative management and was
discharged home. An interval Magnetic Resonance Im-
aging (MRI) scan one month after discharge showed
the pancreas mass had decreased in size and showed
MR characteristics of a haematoma (Figure 2B). A fur-
ther follow-up CT 3 months later showed complete reso-
lution of the pancreatic mass. The patient was discharged
from the care of the hepato-pancreatico-biliary service.
Discussion
To our knowledge, this is the first descriptions of iso-
lated focal haemorrhage in the pancreas as a result of
oral anticoagulation. The periampullary region is
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haemorrhage involving any of its structures can mimic
the presentation of a neoplasm. Although at times chal-
lenging, they can be differentiated by various imaging
modalities from their enhancement pattern, signal charac-
teristics or metabolic activities [2,3]. What is unique in
these two cases is that the patients had isolated focal pan-
creatic parenchymal haemorrhage in the absence of a neo-
plasm, pancreatitis or trauma.
Perhaps it is not surprising that our two cases were
initially misinterpreted as pancreatic malignancies as the
presence of a pancreatic mass is the most common
direct sign of a pancreatic tumour. The most common
type of pancreatic cancer, accounting for over 85% of
these tumours is ductal adenocarcinoma. They often
cause distortion to the contour of the gland, dilated pan-
creatic and common bile ducts, atrophy of the gland, in-
vasion of local vasculature as well as metastases to
regional lymph nodes, liver and the peritoneal cavity [4].
However, haemorrhage can also occur within a pancre-
atic tumour and is common in neoplasms such as solid
pseudopapillary tumours and acinar cell carcinoma [5,6].
Therefore, only by recognizing the lack of indirect
features, other lesions such as haematomas can be distin-
guished from a pancreatic tumour.
Tumoural haemorrhage is not only cause of haemor-
rhage within the pancreas. Pancreatic haemorrhage is
also often associated within pancreatitis, occuring in
20% of cases [7]. Although serum amylase is the most
widely used biochemical test to diagnose acute pancrea-
titis [8], CT plays an ever increasing role in aiding diag-
nosis and predicting clinical outcome [9]. In general,
haemorrhage associated with pancreatitis also exhibit
other signs of pancreatitis, including focal or diffuse pan-
creatic enlargement, pseudoaneurysms, inflammatory
changes in the surrounding peripancreatic space, fluid col-
lection formation and necrosis of the parenhcyma. The
absence of these signs was not recognized which resulted
in the misinterpretation of the radiological findings. If the
CT scan had been performed with a non-contrast phase
followed by arterial and venous phase study, the high
Hounsfield (HU) values on the non-contrast images along
with the lack of increase in HU values following contrast
injection would have helped in making the correct
diagnosis.
Other causes of pancreatic haemorrhage include pancre-
atic injury secondary to trauma or iatrogenic cause (such
as biopsy) [10,11]. In these circumstances, although radio-
logical appearances may be similar to these two cases,
there is usually a clear history for making the diagnosis.
The two cases illustrate the potential morbidity of
anticoagulation therapy. It is estimated that around 1%
of the UK population is on oral anticoagulation therapy
(source IMS Health) and haemorrhage is the mostcommon complication of Warfarin therapy [12]. The risk
of major bleeding is thought to be around 2% in clinical
trials although the incidence of major haemorrhage is un-
known due to the varying dosage used, patient characteris-
tics and differential definitions used by various studies [13].
Multiple factors such as the intensity of anticoagulation,
time from starting anticoagulation therapy, quality of
monitoring, genetic factors, age, gender, co-morbidities,
polypharmacy and patient compliance have all been iden-
tified to be associated with anticoagulation bleeding com-
plications [14].
The importance of recognizing the potential complica-
tions of anticoagulation therapy cannot be understated.
Only by increasing the awareness amongst physicians,
surgeons and radiologists, unnecessary procedures as in
one of our patients who underwent laparotomy and had
a prolonged hospital stay could be avoided.
Conclusion
Haemorrhage secondary to anticoagulation therapy is
common although focal haemorrhage in a solid organ is
rare. These two cases provide a timely reminder of the
potential complications of anticoagulation therapy. Care-
ful analyses of radiological images and an awareness of
the complications of anticoagulation therapy can reduce
morbidity of patients.
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